LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

NVS

150.9

-0.44%↓

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

NVS

150.9

-0.44%↓

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

NVS

150.9

-0.44%↓

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

NVS

150.9

-0.44%↓

LLY

1,122.06

-0.63%↓

JNJ

235.31

-0.25%↓

ABBV

222.61

+0.73%↑

UNH

408.57

-0.43%↓

NVS

150.9

-0.44%↓

Search

AngioDynamics Inc

Cerrado

SectorSanidad

12.14 2.02

Resumen

Variación precio

24h

Actual

Mínimo

11.84

Máximo

12.18

Métricas clave

By Trading Economics

Ingresos

-1.7M

-8.1M

Ventas

-1M

78M

BPA

0.02

Margen de beneficios

-10.308

Empleados

675

EBITDA

-402K

-838K

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+33.56% upside

Dividendos

By Acuity

Próximas Ganancias

14 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

45M

493M

Apertura anterior

10.12

Cierre anterior

12.14

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

166 / 342 Clasificación en Healthcare

AngioDynamics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Acerca de AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
help-icon Live chat